The role of peritoneal dialysis in modern renal replacement therapy

Postgraduate Medical Journal

Volumn 89, Issue 1056, 2013, Pages 584-590

  Goodlad, Catriona ^a   Brown, Edwina ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; ENTEROPATHY; HEALTH CARE COST; HERNIA; HYPERKALEMIA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; LIFESTYLE; META ANALYSIS (TOPIC); MORTALITY; PATIENT SATISFACTION; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PERITONITIS; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; ULTRAFILTRATION;

EID: 84884419424     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2012-131406     Document Type: Review

References (63)

1. UK Renal Registry 14th Annual Report 2011 20 November 2012. http://www.renal.org.
2. Collins AJ, Foley R, Herzog C, et al. Excerpts from the United States Renal Data System 2007 annual data report. Am J Kidney Dis 2008;51(1 Suppl 1):S1-S320.
3. Korevaar J, Boeschoten E, Dekker F, et al. What have we learned from NECOSAD? Practical implications for peritoneal dialysis patients. Perit Dial Int 2007;27:11-15.
4. Brown E, Davies S, Rutherford P, et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003;14:2948-2957.
5. Brown E, Davies S, Heimbürger O, et al. Adequacy targets can be met in anuric patients by automated peritoneal dialysis: baseline data from EAPOS. Perit Dial Int 2001;21(Suppl 3):S133-S137.
6. Davies S, Phillips L, Naish P, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 2001;12:1046-1051.
7. Davies S, Brown E, Frandsen N, et al. Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription. Kidney Int 2005;67:1609-1615.
8. Kawaguchi Y, Kawanishi H, Mujais S, et al. Encapsulating peritoneal sclerosis: definition, etiology, diagnosis, and treatment. International Society for Peritoneal Dialysis Ad Hoc Committee on Ultrafiltration Management in Peritoneal Dialysis. Perit Dial Int 2000;20(Suppl 4):S43-S55.
9. Kawanishi H, Moriishi M. Epidemiology of encapsulating peritoneal sclerosis in Japan. Perit Dial Int 2005;25(Suppl 4):S14-S18.
10. Brown E, Van Biesen W, Finkelstein F, et al. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: position paper for ISPD. Perit Dial Int 2009;29:595-600.
11. Van Biesen W, Vanholder RC, Veys N, et al. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000;11:116-125.
12. Korevaar JC, Feith GW, Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003;64:2222-2228.
13. Quinn RR, Austin PC, Oliver MJ. Comparative studies of dialysis therapies should reflect real world decision-making. J Nephrol 2008;21:139-145.
14. McDonald SP, Marshall MR, Johnson DW, et al. Relationship between dialysis modality and mortality. J Am Soc Nephrol 2009;20:155-163.
15. Huang CC, Cheng KF, Wu HD. Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Perit Dial Int 2008;28(Suppl 3):S15-S20.
16. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002;17:112-117.
17. Liem YS, Wong JB, Hunink MG, et al. Comparison of hemodialysis and peritoneal dialysis survival in The Netherlands. Kidney Int 2007;71:153-158.
18. van Manen JG, van Dijk PC, Stel VS, et al. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. Nephrol Dial Transplant 2007;22:187-195.
19. Moist LM, Port FK, Orzol SM, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000;11:556-564.
20. Molnar MZ, Mehrotra R, Duong U, et al. Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol 2012;7:332-341.
21. Snyder JJ, Kasiske BL, Gilbertson DT, et al. A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 2002;62:1423-1430.
22. Fuquay R, Teitelbaum I. Transplant outcomes and dialysis modality. Contrib Nephrol 2012;178:251-257.
23. Hyphantis T, Katsoudas S, Voudiclari S. Ego mechanisms of defense are associated with patients' preference of treatment modality independent of psychological distress in end-stage renal disease. Patient Prefer Adherence. 2010;4:25-32.
24. Korevaar J, Jansen M, Merkus M, et al. Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy. The NECOSAD Study Group. Perit Dial Int 2000;20:69-75.
25. Juergensen E, Wuerth D, Finkelstein SH, et al. Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol 2006;1:1191-1196.
26. Barendse SM, Speight J, Bradley C. The Renal Treatment Satisfaction Questionnaire (RTSQ): a measure of satisfaction with treatment for chronic kidney failure. Am J Kidney Dis 2005;45:572-579.
27. Liem YS, Bosch JL, Hunink MG. Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 2008;11:733-741.
28. McLaughlin K, Manns B, Mortis G, et al. Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis 2003;41:380-385.
29. Jager KJ, Korevaar JC, Dekker FW, et al. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis 2004;43:891-899.
30. Stack AG. Determinants of modality selection among incident US dialysis patients: results from a national study. J Am Soc Nephrol 2002;13:1279-1287.
31. Rubin HR, Fink NE, Plantinga LC, et al. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004;291:697-703.
32. Liang CH, Yang CY, Lu KC, et al. Factors affecting peritoneal dialysis selection in Taiwanese patients with chronic kidney disease. Int Nurs Rev 2011;58:463-469.
33. Chanouzas D, Ng KP, Fallouh B, et al. What influences patient choice of treatment modality at the pre-dialysis stage? Nephrol Dial Transplant 2012;27:1542-1547.
34. Loeffert S, Ommen O, Kuch C, et al. Configural frequency analysis as a method of determining patients' preferred decision-making roles in dialysis. BMC Med Inform Decis Mak 2010;10:47.
35. Murray MA, Brunier G, Chung JO, et al. A systematic review of factors influencing decision-making in adults living with chronic kidney disease. Patient Educ Couns 2009;76:149-158.
36. Morton RL, Devitt J, Howard K, et al. Patient views about treatment of stage 5 CKD: a qualitative analysis of semistructured interviews. Am J Kidney Dis 2010;55:431-440.
37. Morton RL, Snelling P, Webster AC, et al. Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ 2012;184: E277-E283.
38. Lee A, Gudex C, Povlsen JV, et al. Patients' views regarding choice of dialysis modality. Nephrol Dial Transplant 2008;23:3953-3959.
39. Morton RL, Tong A, Howard K, et al. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. BMJ 2010;340:c112.
40. Baboolal K, McEwan P, Sondhi S, et al. The cost of renal dialysis in a UK setting-a multicentre study. Nephrol Dial Transplant 2008;23:1982-1989.
41. Ledebo I, Ronco C. The best dialysis therapy? Results from an international survey among nephrology professionals. NDT Plus 2008;1:403-408.
42. Jassal SV, Krishna G, Mallick NP, et al. Attitudes of British Isles nephrologists towards dialysis modality selection: a questionnaire study. Nephrol Dial Transplant 2002;17:474-477.
43. Thamer M, Hwang W, Fink NE, et al. US nephrologists' recommendation of dialysis modality: results of a national survey. Am J Kidney Dis 2000;36:1155-1165.
44. Kidney disease: peritoneal dialysis in the treatment of stage 5 chronic kidney disease2011 20 November 2012. http://www.nice.org.uk/guidance/CG125
45. Junejo K, Jeboda F, Chawdhery MZ, et al. Use of embedded peritoneal dialysis catheters-a UK perspective and a single center's experience. Perit Dial Int 2008;28:305-308.
46. Elhassan E, McNair B, Quinn M, et al. Prolonged duration of peritoneal dialysis catheter embedment does not lower the catheter success rate. Perit Dial Int 2011;31:558-564.
47. Povlsen JV, Ivarsen P. Assisted peritoneal dialysis: also for the late referred elderly patient. Perit Dial Int 2008;28:461-467.
48. Campbell AJ, Buchner DM. Unstable disability and the fluctuations of frailty. Age Ageing 1997;26:315-318.
49. Johansen KL, Chertow GM, Jin C, et al. Significance of frailty among dialysis patients. J Am Soc Nephrol 2007;18:2960-2967.
50. Oliver MJ, Garg AX, Blake PG, et al. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant 2010;25:2737-2744.
51. Brown EA, Johansson L, Farrington K, et al. Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant 2010;25:3755-3763.
52. Kooman JP, Cornelis T, van der Sande FM, et al. Renal replacement therapy in geriatric end-stage renal disease patients: a clinical approach. Blood Purif 2012;33:171-176.
53. Burns A, Carson R. Maximum conservative management: a worthwhile treatment for elderly patients with renal failure who choose not to undergo dialysis. J Palliat Med 2007;10:1245-1247.
54. Sunder S, Taskapan H, Jojoa J, et al. Chronic peritoneal dialysis in the tenth decade of life. Int Urol Nephrol 2004;36:605-609.
55. Janssen DJ, Spruit MA, Schols JM, et al. Insight into advance care planning for patients on dialysis. J Pain Symptom Manage 2013;45:104-113.
56. Oliver MJ, Quinn RR, Richardson EP, et al. Home care assistance and the utilization of peritoneal dialysis. Kidney Int 2007;71:673-678.
57. Castrale C, Evans D, Verger C, et al. Peritoneal dialysis in elderly patients: report from the French Peritoneal Dialysis Registry (RDPLF). Nephrol Dial Transplant 2010;25:255-262.
58. Benain JP, Faller B, Briat C, et al. Cost of dialysis in France. Nephrol Ther 2007;3:96-106.
59. Xu R, Zhuo M, Yang Z, et al. Experiences with assisted peritoneal dialysis in China. Perit Dial Int 2012;32:94-101.
60. Brown EA. How to address barriers to peritoneal dialysis in the elderly. Perit Dial Int 2011;31(Suppl 2):S83-S85.
61. Zhang AH, Bargman JM, Lok CE, et al. Dialysis modality choices among chronic kidney disease patients: identifying the gaps to support patients on home-based therapies. Int Urol Nephrol 2010;42:759-764.
62. Mendelssohn DC. A skeptical view of assisted home peritoneal dialysis. Kidney Int 2007;71:602-604.
63. Dratwa M. Costs of home assistance for peritoneal dialysis: results of a European survey. Kidney Int Suppl 2008:S72-S75.